
Site burden is now measured through satisfaction surveys, in-the-moment check-ins, and adoption patterns, but each method catches a different moment, and the gaps between them decide whether teams can act before burden becomes risk.
Click the title above to open the Applied Clinical Trials November/December 2017 issue in an interactive PDF format.
almost 9 years ago
FDA Seeks Innovative Research Strategies to Bring New Cures to Patientsalmost 9 years ago
What Can You Do to Prevent Clinical Trial Fraud?almost 9 years ago
The ‘What Ifs’ of EMA Relocation Decisionalmost 9 years ago
Addressing Administrative and Adherence Burdens in Clinical Trialsalmost 9 years ago
Anticipating the Groundswell of RWD and RWE Usagealmost 9 years ago
M&A, FDA Top List of 2017 Happeningsalmost 9 years ago
Improving the Traceability of the Clinical Trial Supply Chainalmost 9 years ago
Site Perspectives on Clinical Trial Qualityalmost 9 years ago
Salary and Satisfaction





